- Home
- OFLX vs GOSS Comparison
OFLX vs GOSS Comparison
Compare OFLX & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- GOSS
- Stock Information
- Founded
- OFLX 1975
- GOSS 2015
- Country
- OFLX United States
- GOSS United States
- Employees
- OFLX N/A
- GOSS N/A
- Industry
- OFLX Industrial Specialties
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- GOSS Health Care
- Exchange
- OFLX Nasdaq
- GOSS Nasdaq
- Market Cap
- OFLX 366.4M
- GOSS 347.8M
- IPO Year
- OFLX 2005
- GOSS 2019
- Fundamental
- Price
- OFLX $35.30
- GOSS $2.47
- Analyst Decision
- OFLX
- GOSS Strong Buy
- Analyst Count
- OFLX 0
- GOSS 4
- Target Price
- OFLX N/A
- GOSS $8.50
- AVG Volume (30 Days)
- OFLX 22.3K
- GOSS 3.1M
- Earning Date
- OFLX 10-29-2025
- GOSS 08-05-2025
- Dividend Yield
- OFLX 3.85%
- GOSS N/A
- EPS Growth
- OFLX N/A
- GOSS N/A
- EPS
- OFLX 1.69
- GOSS N/A
- Revenue
- OFLX $100,700,000.00
- GOSS $40,237,000.00
- Revenue This Year
- OFLX N/A
- GOSS N/A
- Revenue Next Year
- OFLX N/A
- GOSS $30.65
- P/E Ratio
- OFLX $20.93
- GOSS N/A
- Revenue Growth
- OFLX N/A
- GOSS N/A
- 52 Week Low
- OFLX $28.12
- GOSS $0.66
- 52 Week High
- OFLX $57.81
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- OFLX 57.66
- GOSS 68.08
- Support Level
- OFLX $34.25
- GOSS $2.38
- Resistance Level
- OFLX $37.50
- GOSS $2.65
- Average True Range (ATR)
- OFLX 1.08
- GOSS 0.15
- MACD
- OFLX 0.26
- GOSS 0.03
- Stochastic Oscillator
- OFLX 54.73
- GOSS 76.67
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.